Suppr超能文献

左心室辅助装置植入住院结局中的“吸烟者悖论”:基于2015 - 2021年全国住院患者样本的人群分析

"Smoker's paradox" in in-hospital outcomes of left ventricular assist device implantation: a population-based analysis of National Inpatient Sample from 2015-2021.

作者信息

Li Renxi, Prastein Deyanira J, Boyce Steven W

机构信息

The George Washington University School of Medicine and Health Sciences, 2300 I St NW, Washington, D.C., 20052, USA.

Department of Surgery, The George Washington University Hospital, Washington, D.C., USA.

出版信息

J Artif Organs. 2025 May 26. doi: 10.1007/s10047-025-01515-w.

Abstract

Left ventricular assist device (LVAD) implantation is a treatment option for advanced heart failure. The relationship between smoking and perioperative outcomes in LVAD implantation remains inconclusive, as evidence has been limited to single-center studies. This study aimed to examine the association between smoking and in-hospital outcomes of LVAD implantation in a large-scale population-based analysis. Patients who underwent LVAD implantation were selected from National Inpatient Sample from Q4 2015-2021. Multivariable logistic regression was used to compare in-hospital outcomes between smokers and non-smokers, where demographics, socioeconomic status, primary payer status, hospital characteristics, comorbidities, and transfer/admission status were adjusted. There were 1346 (26.5%) smokers and 3737 (73.5%) non-smokers who underwent LVAD implantation. Smokers presented with a higher burden of comorbidities. After multivariable adjustment, smokers had lower in-hospital mortality (aOR 0.68, 95 CI 0.52-0.889, p < 0.01), MACE (aOR 0.74, 95 CI 0.554-0.987, p = 0.04), neurological complications (aOR 0.555, 95 CI 0.367-0.839, p = 0.01), stroke (aOR 0.508, 95 CI 0.311-0.832, p = 0.01), pericardial complications (aOR 0.705, 95 CI 0.545-0.913, p = 0.01), renal complications (aOR 0.691, 95 CI 0.595-0.801, p < 0.01), venous thromboembolism (aOR 0.523, 95 C = 0.295-0.929, p = 0.03), hemorrhage/hematoma (aOR 0.746, 95 CI 0.641-0.869, p < 0.01), and superficial wound complication (aOR 0.458, 95 CI 0.286-0.733, p < 0.01). Moreover, smokers had a shorter time from admission to operation (p = 0.02), shorter length of stay (p < 0.01), lower transfer out rate (p < 0.01), and lower hospital charge (p < 0.01). This study uncovered a "smoker's paradox" in LVAD implantation. These findings added to the long-standing observation of a "smoker's paradox" in cardiac surgery. However, the underlying reasons require further investigation.

摘要

左心室辅助装置(LVAD)植入是晚期心力衰竭的一种治疗选择。吸烟与LVAD植入围手术期结局之间的关系尚无定论,因为证据仅限于单中心研究。本研究旨在通过大规模基于人群的分析,探讨吸烟与LVAD植入住院结局之间的关联。2015年第四季度至2021年期间,从国家住院患者样本中选取接受LVAD植入的患者。采用多变量逻辑回归比较吸烟者和非吸烟者的住院结局,并对人口统计学、社会经济状况、主要支付者状况、医院特征、合并症以及转诊/入院状况进行了调整。共有1346名(26.5%)吸烟者和3737名(73.5%)非吸烟者接受了LVAD植入。吸烟者的合并症负担更高。多变量调整后,吸烟者的住院死亡率较低(调整后比值比[aOR]为0.68,95%置信区间[CI]为0.52-0.889,p<0.01)、主要不良心血管事件(aOR为0.74,95%CI为0.554-0.987,p=0.0)、神经系统并发症(aOR为0.555,95%CI为0.367-0.839,p=0.01)、中风(aOR为0.508,95%CI为0.311-0.832,p=0.01)、心包并发症(aOR为0.705,95%CI为0.545-0.913,p=0.01)、肾脏并发症(aOR为0.691,95%CI为0.595-0.801,p<0.01)、静脉血栓栓塞(aOR为0.523,95%CI为0.295-0.929,p=0.03)、出血/血肿(aOR为0.746,95%CI为0.641-0.869,p<0.01)和浅表伤口并发症(aOR为0.458,95%CI为0.286-0.733,p<0.01)。此外,吸烟者从入院到手术的时间更短(p=0.02)、住院时间更短(p<0.01)、转出率更低(p<0.01)且住院费用更低(p<0.01)。本研究发现了LVAD植入中的“吸烟者悖论”。这些发现进一步证实了心脏手术中长期存在的“吸烟者悖论”。然而,其潜在原因仍需进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验